首页|干扰素α2b和抗真菌药物联合乳杆菌胶囊在复发性外阴阴道假丝酵母菌病治疗中的应用研究

干扰素α2b和抗真菌药物联合乳杆菌胶囊在复发性外阴阴道假丝酵母菌病治疗中的应用研究

扫码查看
目的 探讨干扰素α2b、唑类抗真菌药物联合乳杆菌胶囊在复发性外阴阴道假丝酵母菌病治疗中的应用效果.方法 选取100例复发性外阴阴道假丝酵母菌病(RVVC)且真菌培养结果为白假丝酵母菌的患者,采用随机数字表法分为联合用药组1和联合用药组2,每组50例.联合用药组1使用氟康唑冲击疗法,同时阴道使用克霉唑阴道片,连续用药6个月.联合用药组2在联合用药组1的基础上增加使用乳杆菌胶囊和干扰素α2b阴道泡腾片,连续治疗6个月.每个月患者到院进行妇检及阴道分泌物微生态检测,比较两组的治疗效果.结果 治疗6个月后,与联合用药组1相比,联合用药组2的白假丝酵母菌培养阳性率、临床症状评分、革兰阳性球菌、动弯杆菌和假丝酵母菌菌丝检出和菌群密集度下降,白带清洁度和乳杆菌比例、菌群多样性、H202含量、Nugent评分和AV评分正常者上升,白细胞酯酶和唾液酸苷酶阴性及阴道微生态平衡者比例上升,治疗期间或3个月内联合用药组1复发率高于联合用药组2(P<0.05).两组停药3~6个月的治疗有效率和停药6个月的治愈率比较,差异具有统计学意义(P<0.05).结论 干扰素α2b、唑类抗真菌药物联合乳杆菌胶囊可促进患者的阴道微生态环境恢复,在复发性外阴阴道假丝酵母菌病治疗中效果显著,值得临床推广与应用.
Application of interferon-a2b and antifungal drugs combined with Lactobacillus capsules in the treatment of recurrent vulvovaginal candidiasis
Objective To explore the application of interferon-α2b and antifungal drugs combined with Lactobacillus capsules in the treatment of recurrent vulvovaginal candidiasis(RVVC).Methods 100 patients with recurrent vulvovaginal candidiasis(RVVC)with fungal culture results of Candida alba were selected and divided into combined treatment group 1 and combined treatment group 2 with 50 cases in each group by random number table method.Group 1 received fluconazole shock therapy and clotrimazole vaginal tablets for 6 months.In combination group 2,Lactobacillus capsules and interferon α2b vaginal effervescent tablets were added to combination group 1 for 6 months.Every month,the patients went to the hospital for gynecological examination and vaginal secretion microecological detection,and compared the treatment effect of the two groups.Results After 6 months of treatment,compared with the combined treatment group 1,the positive rate of candida alba culture,clinical symptom score,gram-positive coccus,Campylobacter and candida alba mycelium detection and bacterial population density decreased in the combined treatment group 2,while the cleanliness of leucorrhea,lactobacillus proportion,bacterial diversity,H2O2 content,Nugent score and AV score increased in the combined treatment group 2.The proportion of patients with negative leucocyte esterase and sialoglycosidase and vaginal microecological balance increased,and the recurrence rate of combined treatment group 1 was higher than that of combined treatment group 2 during treatment or within 3 months(P<0.05).There were significant differences between the two groups in the effective rate and the cure rate after 3 to 6 months of discontinuation(P<0.05).Conclusion The combination of interferon-α2b and azole antifungal drugs with Lactobacillus capsules can promote the recovery of vaginal microecological environment in patients with RVVC,the treatment of RVVC is effective,which is worthy of further promotion and application.

Recurrent vulvovaginal candidiasisInterferonLactobacillus capsulesVaginal Microecology

张流、麦美云、周恒

展开 >

柳州市妇幼保健院(广西科技大学附属妇产医院、儿童医院

广西妇产疾病临床医学研究中心)妇科门诊,广西 柳州 545000

复发性外阴阴道假丝酵母菌病 干扰素 乳杆菌胶囊 阴道微生态

广西科技计划项目广西壮族自治区卫生健康委员会自筹经费科研项目

桂科AD22035223Z20190611

2024

实用妇科内分泌电子杂志

实用妇科内分泌电子杂志

ISSN:
年,卷(期):2024.11(16)